Steven M Belknap

  • 2653 Citations
1987 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

I am interested in computational medicine and specifically pharmacoalgorithmics, informally defined as "the study of what the drug prescription does to the patient." Drug therapy is more than just drugs, it includes the instructions for safely and effectively using the drugs and the resources to support those instructions (e.g., nurses, pharmacists, physicians, infusion pumps, and drug concentration measurements). A prescription is a health-care program implemented by a physician or other qualified practitioner in the form of instructions that govern the plan of care for an individual patient. Working with a team of investigators, I showed that application of computer programming design and debugging methods results in a marked increase in the safety of opioid prescriptions in hospitalized adults. The methods we have developed in pharmacoalgorithmics have application to reducing the risk of adverse drug events, optimizing the efficacy of drug therapy, and reducing the cost of medical care.

Training Experience

1985Residency, Roger Williams General Hospital

Education/Academic qualification

MD, Northwestern University Feinberg School of Medicine

… → 1982

Research interests

  • Clinical Pharmacology
  • Internal Medicine / General Medicine

Fingerprint Dive into the research topics where Steven M Belknap is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

  • Research Output

    POP-PL: A patient-oriented prescription programming language

    Florence, S. P., Fetscher, B., Flatt, M., Temps, W. H., St Amour, V., Kiguradze, T., West, D. P., Niznik, C., Yarnold, P. R., Findler, R. & Belknap, S. M., Aug 2018, In : ACM Transactions on Programming Languages and Systems. 40, 3, A10.

    Research output: Contribution to journalArticle

  • Commentary

    Belknap, S. M., Feb 21 2017, In : Annals of internal medicine. 166, 4, p. JC23

    Research output: Contribution to journalComment/debate

    Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride

    Kiguradze, T., Temps, W. H., Yarnold, P. R., Cashy, J., Brannigan, R. E., Nardone, B., Micali, G., West, D. P. & Belknap, S. M., Jan 1 2017, In : PeerJ. 2017, 3, e3020.

    Research output: Contribution to journalArticle

  • 27 Scopus citations

    Score of Toxic Epidermal Necrosis Predicts the Outcomes of Pediatric Epidermal Necrolysis

    Sorrell, J., Anthony, L., Rademaker, A. W., Belknap, S. M., Callahan, S., West, D. P. & Paller, A., Jul 1 2017, In : Pediatric Dermatology. 34, 4, p. 433-437 5 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations